Ruairi J Mackenzie
Technology Networks
RJ is a freelance science writer based in Glasgow. He covers biological and biomedical science, with a focus on the complexities and curiosities of the brain and emerging AI technologies. RJ was a science writer at Technology Networks for six years, where he also worked on the site’s SEO and editorial AI strategies. He created the site’s podcast, Opinionated Science, in 2020. RJ has a Master’s degree in Clinical Neurosciences from the University of Cambridge.
Got a question for Ruairi J Mackenzie?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 609
Infographic
RNA-seq in Neuroscience
RNA-seq has shown its worth across many fields, and neuroscience is no exception. In this infographic, we’ll investigate RNA-seq, how it is used in neuroscience, and how it has the potential to advance our understanding of every cell in the brain.
Industry Insight
The Booming Business of Neurotoxin Therapy
Botulinum neurotoxins are widely used in both therapeutic and cosmetic applications, but Ipsen says that their new rBoNT-E toxin is a step up from compounds based on the much more widely used serotype A toxin. We spoke to Ipsen Senior Vice President Neurosciences R&D, Philippe Picaut, to find out more.
News
Neuroticism Could Lead to Depression, Says Largest-ever Genetic Analysis
A new study has leveraged genetic datasets to uncover genes linked to depression. The research identified 269 genes associated with the condition. Scientists also deployed innovative statistical techniques to connect specific behaviors to depression. Their analysis provides evidence that neurotic behaviors could lead people to become depressed.
Industry Insight
The Biggest Challenges for Data Integrity
Ensuring that data is reliable, reproducible, and therefore valuable means companies in both regulated and non-regulated spaces must keep data integrity at the heart of their informatics operations. We talked to John Zenk, Validation Services Manager at laboratory informatics consultancy CSols, Inc, to find out what the biggest concerns in data integrity are and how companies can take steps to overcome these challenges.
Industry Insight
Can We Treat Mood Disorders with Pharmacological Therapeutics?
Clinical treatments for neurological and mood disorders like social anxiety disorder and major depressive disorder have failed to show consistent efficacy in treating patients. VistaGen Therapeutics is aiming to correct that. We talked to VistaGen’s CEO, Shawn Singh, about the need for treatments in this area and why Vistagen thinks their compounds AV-101 and PH94B could be promising therapies.
Industry Insight
Supporting Drug Discovery with Cell-centered Models of the Immune System
Many biological processes, specifically the immune system, operate at a cellular level. CytoReason have harnessed this knowledge to build computational, high-resolution, mechanistic models for a range of diseases that enables better discovery and validation of drug targets.
Article
ROCKbusting Huntington’s and Probing Parkinson’s
At the Society for Neuroscience (SfN) conference last held in November 2018 in San Diego, a truly frightening number of posters were presented over nine sessions. In this article we look in-depth at posters shared by Charles River Laboratories, highlighting research into Huntington's Disease and Parkinson's Disease.
Industry Insight
Microfluidics Solutions to Proteomics Problems
Microfluidic platforms are becoming commonplace across biological science. To find out more about how microfluidic technology is revolutionizing protein analysis, we spoke to Tuomas Knowles, Founder and Chief Scientific Officer, Fluidic Analytics.
Industry Insight
Building a Smart City
Cities often don't work very well. Bins don't get collected. Traffic queues are long. Shops run out of goods. The Russian team behind Airalab think that AI can help streamline cities and the economy more widely. Their Robonomics platform aims to make it easier to bring automated, intelligent technology into the economy. With Smart City projects already on the go, from Dubai to Milton Keynes, we spoke to Airalab's Aleksandr Kapitonov to find out more.
Article
ELN, LIMS, CDS, LES: What’s the Difference?
In this article, we look at the key differences between four common types of informatics systems. CSols Inc. is an independent informatics consultancy, and their Delivery Manager, Geoff Turnbull, will help us answer some important questions on the role these systems play, where they overlap with each other, and why we don’t just have one overarching system to rule them all.
Advertisement
